Clinical Trial Update: Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting long-term antibody persistence after vaccination with meningococcal, pneumococcal, and Hib vaccines in children up to 6 years old…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Neisseria Meningitidis Disease

Drugs mentioned

• Meningococcal, Pneumococcal and Hib vaccines (GlaxoSmithKline)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neisseria Meningitidis, Haemophilus Influenzae Type b | Phase 3 | Status: COMPLETED | Results posted: 2010-12-23